Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143

Montefiore Medical Center PRIME, The Bronx

St. Luke's University Health Network, Bethlehem

Georgetown University - Lombardi Comprehensive Cancer Center, Northwest

START Madrid, Fundacion Jimenez Diaz, Madrid

START Madrid, H.U. Sanchinarro, Madrid

Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse

University of Florida, Gainesville

UC Health, LLC., Cincinnati

Rush University Medical Center, Chicago

Washington University, St Louis

Centre Leon Berard, Lyon

Methodist Hospital, Houston Methodist Cancer Center, Houston

Institut Gustave Roussy, Villejuif

H. Lee Moffitt Cancer Center and Research Institute, Tampa

Beth Israel Deaconess Medical Center, Boston

Dana-Farber/Partners Cancer Care, Boston

Hospital Vall d'Hebron, Barcelona